Global Cord Blood
CORBF
$0.71
Share price
29.09%
Change (1 day)
-52.67%
Change (1 year)
Categories
Revenue for Global Cord Blood (CORBF)
Revenue in 2022 (TTM): $0.19 Billion USD
According to Global Cord Blood's latest financial reports the company's current revenue (TTM 
) is $0.19 Billion USD. In 2021 the company made a revenue of $0.19 Billion USD an increase over the revenue in the year 2020 that were of $0.16 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Global Cord Blood from 2009 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.19 B | 0.38% |
| 2021 | $0.19 B | 14.6% |
| 2020 | $0.16 B | -0.19% |
| 2019 | $0.16 B | 16.35% |
| 2018 | $0.14 B | 7.38% |
| 2017 | $0.13 B | 26.39% |
| 2016 | $0.10 B | 0.82% |
| 2015 | $0.10 B | 5.18% |
| 2014 | $0.10 B | 11.61% |
| 2013 | $90.46 M | 15.4% |
| 2012 | $78.38 M | 33.94% |
| 2011 | $58.52 M | 24.44% |
| 2010 | $47.03 M | 68.26% |
| 2009 | $27.95 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Cryo-Cell CCEL | $32.1 M | -83.46% | 🇺🇸 USA |
 NeoGenomics
NEO | $0.67 B | 246.31% | 🇺🇸 USA |
 RadNet RDNT | $1.86 B | 862.85% | 🇺🇸 USA |
 National Healthcare
NHC | $1.37 B | 607.94% | 🇺🇸 USA |